Patent application number | Description | Published |
20080214576 | Topoisomerase Inhibitors and Prodrugs - Compositions and methods for treating cancer and other hyperproliferatice disease conditions with topoisomerase inhibitors and their prodrugs are disclosed. | 09-04-2008 |
20090042820 | Tubulin Binding Anti Cancer Agents And Prodrugs Thereof - Novel tubulin binding compounds and hypoxia activated prodrugs of novel and known tubulin binding compounds useful for treating cancer and other hyperproliferative diseases are disclosed. | 02-12-2009 |
20090312276 | Compositions and Methods for Treating Cancer - Hypoxia-activated prodrugs can be used to treat cancer when administered alone or in combination with one or more anti-neoplastic agents. | 12-17-2009 |
20100104549 | GLUFOSFAMIDE COMBINATION THERAPY - The co-administration of glufosfamide and a glucose lowering drug other than insulin is efficacious in cancer treatment. | 04-29-2010 |
20100137254 | PHOSPHORAMIDATE ALKYLATOR PRODRUGS - Phosphoramidate alkylator prodrugs can be used to treat cancer when administered along or in combination with one or more anti-neoplastic agents. | 06-03-2010 |
20110251159 | Phosphoramidate Alkylator Prodrugs - Phosphoramidate alkylator prodrugs can be used to treat cancer when administered alone or in combination with one or more anti-neoplastic agents. | 10-13-2011 |
20130202716 | Treatment of Cancer Using Hypoxia Activated Prodrugs - Cancer can be treated by administration of a hypoxia-activated prodrug, such as TH-302, alone or in combination with other anticancer agents and/or radiation therapy. In combination therapy, the hypoxia-activated prodrug and another anti-cancer agent or radiation therapy may be administered within the same 24-hour period, and administration of the hypoxia-activated prodrug may be completed prior to beginning administration of the other anticancer agent or radiation therapy. | 08-08-2013 |
20130303778 | PHOSPHORAMIDATE ALKYLATOR PRODRUGS - Phosphoramidate alkylator prodrugs can be used to treat cancer when administered alone or in combination with one or more anti-neoplastic agents. | 11-14-2013 |
20140170240 | Phosphoramidate Alkylator Prodrugs - Phosphoramidate alkylator prodrugs can be used to treat cancer when administered alone or in combination with one or more anti-neoplastic agents. | 06-19-2014 |